An antitumor peptide RS17‐targeted CD47, design, synthesis, and antitumor activity
Abstract Background CD47 is a widely expressed transmembrane protein located on the surface of somatic cells. It mediates a variety of cellular processes including apoptosis, proliferation, adhesion, and migration. An important role for CD47 is the transmission of a “Don't eat me” signal by int...
Main Authors: | Xinmin Wang, Ying Wang, Jialiang Hu, Hanmei Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-03-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.3768 |
Similar Items
-
The landscape overview of CD47-based immunotherapy for hematological malignancies
by: Hua Yang, et al.
Published: (2023-02-01) -
Overcoming immunotherapeutic resistance in PDAC: SIRPα-CD47 blockade
by: Abdullahi Alausa, et al.
Published: (2022-07-01) -
Role of CD47-SIRPα Checkpoint in Nanomedicine-Based Anti-Cancer Treatment
by: Haiqin Liao, et al.
Published: (2022-04-01) -
Tolerating CD47
by: Jeffrey S. Isenberg, et al.
Published: (2024-02-01) -
Cancer Therapy Targeting CD47/SIRPα
by: Nazli Dizman, et al.
Published: (2021-12-01)